Cita APA

Breccia, M., Salaroli, A., Loglisci, G., Finsinger, P., Serrao, A., & Alimena, G. (2012). MDS-specific comorbidity index is useful to identify myelodysplastic patients who can have better outcome with 5-azacitidine. Ferrata Storti Foundation.

Chicago Style Citation

Breccia, Massimo, Adriano Salaroli, Giuseppina Loglisci, Paola Finsinger, Alessandra Serrao, i Giuliana Alimena. MDS-specific Comorbidity Index Is Useful to Identify Myelodysplastic Patients Who Can Have Better Outcome With 5-azacitidine. Ferrata Storti Foundation, 2012.

Cita MLA

Breccia, Massimo, et al. MDS-specific Comorbidity Index Is Useful to Identify Myelodysplastic Patients Who Can Have Better Outcome With 5-azacitidine. Ferrata Storti Foundation, 2012.